Processing .....please wait.. 
The article has been forwarded.... 
India new hub for clinical trials
By agencies
|
Wednesday, 26 October 2005, 19:30 IST
NEW DELHI: India is attracting the attention of clinical research organizations with its vast pool of patients.
Higher costs and inefficient recruitment in the U.S. and Europe are prompting CROs to look to Asia, Latin America and East Europe for good clinical practices, the phrase used in medical parlance.
Backed by well-developed IT infrastructure, CROs are betting it big on India. Giving a perspective of the emerging regulatory scenario on clinical trials in India, Ashwini Kumar, drug controller-general of India, said, "We have come out with a policy statement on training of subject experts for clinical trial inspections and have initiated Central Drugs Standard Control Organization trials for GCP inspections in October 2005."
He was explaining some of the regulatory initiatives taken for providing credible clinical research by ensuring credibility of data submitted to support new drug applications and safety of human trials.
India is projected to have accelerated growth in this sector with the entry of a number of major global and domestic players and the expected transformation in the pharmaceutical industry giving drug discovery research a higher priority.